Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Lung Cancer Screening: Update 2012

Monday, Nov. 26, 8:30-10:00 a.m.| E405A
This session presents the issues involved in planning and establishing a lung cancer screening program. It features a discussion of the risks and benefits of screening and a discussion of the National Lung Screening Trial, and also will cover the resources needed to undertake a screening program.

Techniques for Quantitative Cancer Imaging: Current Status

Sunday, Nov. 25, 2:00-3:30 p.m. | S404AB
Speakers will discuss quantitative imaging applications of CT, MRI and PET. Specific topics include development of a new response assessment criteria based on tumor volume and density changes on CT, use of dynamic-contrast enhanced MRI and diffusion-weighted imaging and techniques for reducing variability in quantitative PET/CT imaging.

Post-op rad therapy slows progression of prostate cancer in 60% of men

Radiotherapy immediately following removal of the prostate has long-term benefits for preventing the biochemical progression of prostate cancer, with more than 60 percent of men remaining disease-free after a decade, according to a study published online first in The Lancet.

ABCs of CT purchases; it's not so simple

With a widening array of CT scanner options, purchasers need to be aware of what each manufacturer offers and avoid some common sources of confusion, according to an Oct. 17 web conference presented by the ECRI Institute.

Florbetapir PET may predict cognitive decline, Alzheimer’s conversion

Individuals at risk for progressive cognitive decline who had amyloid-positive florbetapir PET results performed worse on cognitive assessments and were more likely to convert to Alzheimer’s disease within 18 months than those with amyloid-negative results, according to a study published Oct. 16 in Neurology.

Two modalities are better than one: PET/CT IDs distant malignancies

Whole-body PET/CT has demonstrated excellent diagnostic performance for the detection of distant malignancies, according to a meta-analysis of medical literature published online ahead of print in the Journal of Nuclear Medicine.

U.K. researchers aim to predict cancer risk, streamline diagnosis

U.K. researchers have launched the CANcer DIagnosis Decision (CANDID) rules study, with the goal of predicting who is at higher risk for cancer. Ultimately, such information may help curb unnecessary diagnostic procedures.

Fleischner Society takes aim at incidental subsolid pulmonary nodules

In an effort to plug gaps in its original recommendations for the management of pulmonary nodules, the Fleischner Society issued six recommendations for follow-up of subsolid nodules detected by CT imaging.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.